Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Zomarist

Zomarist 50 mg/850 mg film-coated tablets Zomarist 50 mg/1000 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 8–9

HOS-210484 · Präparat HOS-154523

8  Gastrointestinal disorders Vomiting Common Diarrhoea Common Nausea Common Gastro-oesophageal reflux disease Common Flatulence Common Constipation Common Abdominal pain including upper Common Pancreatitis Uncommon Hepatobiliary disorders Hepatitis Uncommon Skin and subcutaneous tissue disorders Hyperhidrosis Common Pruritis Common Rash Common Dermatitis Common Erythema Uncommon Urticaria Uncommon Exfoliative and bullous skin lesions, including Not known† bullous pemphigoid Cutaneous vasculitis Not known† Musculoskeletal and connective tissue disorders Arthalgia Common Myalgia Uncommon General disorders and administration site conditions Asthenia Common Fatigue Uncommon Chills Uncommon Oedema peripheral Uncommon Investigations Abnormal liver function tests Uncommon * Adverse reactions reported in patients who received metformin as monotherapy and that were not observed in patients who received vildalgiptin+metformin fixed dose combination. Refer to summary of product characteristics for metformin for additional information. † Based on post-marketing experience.

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.